Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegaserod in opioid-induced constipation (OIC)
NCT00414024Phase 3Terminated
- Sponsor
- Novartis
- Start
- Feb 2007
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of tegaserod in opioid-induced constipation (OIC), sponsored by Novartis. Started Feb 2007; status: terminated.
02
Drugs
tegaserod
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00414024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414024.